Kyotsujigyo
  Contact us
home   |   what's new  |   company profile   |   research   |   partners   |   sitemap


What's New | Past News

Melanin may protect against obesity related chronic diseases—fatty liver, liver cancer


hepatitis C   fatty liver   liver disease   liver cirrhosis   NASH liver
Samples from the morbidly obese undergoing weight loss surgery showed that melanin - a pigment giving skin and hair their distinctive colour - was being produced in their fat tissue. Melanin production has never before been identified in fat tissue.

The researchers believe the antioxidant, having anti-inflammatory properties, could be the body's natural defence against obesity-related conditions such as type-2 diabetes, coronary heart disease, fatty liver disease, polycystic ovary syndrome and some cancers.

They explained that, stockpiling extra calories is difficult even for specialized fat cells; having too much lipid molecules takes its toll on the fat cells, producing oxidative stress. It's not unthinkable that these cells would adapt and produce melanin as a form of self-protection. As a side benefit, melanin may suppress inflammatory properties of the extra pounds of the fat.

A larger study is needed in order to confirm the role that the body's production of this compound plays in fat tissue. However, the discovery suggests that melanin-based therapies may one day be used to reduce the incidence of chronic diseases among the morbidly obese.



    2008-11-11

Lessening the Burden of Hepatitis B Virus Infection and Liver Cancer
A Liver Of Love
MRI Techniques Evolving Towards Better Assessment Of Liver Fibrosis
Zetia marketers never fully revealed liver risks: NewYork Times
Do Stem Cells Play a Prime Role in Cancer?
European Medicines Agency Recommends no Lumiracoxib-Containing Medicines
Mobile phone monitors Christmas liver abuse
Hepatitis B Vaccine Not Associated With Childhood Multiple Sclerosis
Government urged to provide liver transplantation centers
No Link Between Hepatitis B Shot, MS: Study
Mexican vanilla extract could cause liver failure
Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma.


home   |   what's new  |   company profile   |   research   |   partners   |   Contact us  |   sitemap
kenkyusho ltd 1999 - 2008©